MODERN CONCEPTS OF COMPLEX THERAPY OF HUMAN PAPILLOMAVIRUS INFECTION
- Authors: Balushkina A.A1, Kan N.E1, Tyutyunnik V.L1
-
Affiliations:
- National Medical Research Center for Obstetrics, Gynecology and Perinatology n.a. Acad. V.I. Kulakov
- Issue: No 6 (2018)
- Pages: 9-14
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/295335
- ID: 295335
Cite item
Open Access
Access granted
Abstract
According to WHO, about 20 million people worldwide are currently infected with human papillomavirus (HPV). Low sexual culture of the population, frequent change of sexual partners increase the risk of developing HPV infection, contribute to the growth of the number of inflammatory diseases of the genital tract, which subsequently leads to violations of the reproductive function, as well as to the development of precancerous cervical diseases. The above-mentioned facts determine the search for effective therapy of HPV infection in order to prevent the development of cervical cancer. The article presents modern data on the feasibility of comprehensive treatment of HPV, which includes not only influence on pathologically altered tissues, but also non-specific antiviral and immunomodulating therapy
Full Text
About the authors
A. A Balushkina
National Medical Research Center for Obstetrics, Gynecology and Perinatology n.a. Acad. V.I. KulakovMoscow
N. E Kan
National Medical Research Center for Obstetrics, Gynecology and Perinatology n.a. Acad. V.I. KulakovMoscow
V. L Tyutyunnik
National Medical Research Center for Obstetrics, Gynecology and Perinatology n.a. Acad. V.I. Kulakov
Email: tioutiounnik@mail.ru
- MD, Head of the 1st Obstetric Physiological Department Moscow
References
- Бахидзе Е.В., Берлев И.В., Архангельская П.А. Возможности противовирусного и иммуномодулирующего лечения у больных преинвазивными неоплазиями шейки матки. Вопр. онкологии. 2015;61(2):205-7.
- Серов В.Н., Кира Е.Ф., Аполихина И.А., Антонова И.Б. и др. Гинекология: Руководство для врачей/ Под ред. В.Н. Серова, Е.Ф. Кира. М., 2008. 840 с.
- Долгушина В.Ф., Ахматова А.Н., Беренда М.А. Эффективность Изопринозина в лечении хронического цервицита, ассоциированного с папилломавирусной инфекцией. Фарматека. 2009;14:73-6.
- Кедрова А.Г., Леваков С.А., Челнокова Н.Н. Оптимизация медикаментозной терапии начальных повреждений эпителия шейки матки, ассоциированных с вирусом папилломы человека. Акушерство и гинекология. 2014;8:88-93.
- Косенко И.А, Костевич Г.В., Артемьева Т.П. и др. К вопросу о патогенезе, диагностике и лечении вирус-ассоциированной патологии шейки матки. Мед. новости. 2016; 2:17-21.
- Мотовилова Т.М. Патология шейки матки на фоне папилломавирусной инфекции: реально ли справиться с рецидивами? Клинический опыт использования технологии аблации и инозина пранобекса в комплексном лечении пациенток репродуктивного возраста. РМЖ. 2015;1:20-4.
- НеймаркБ.А, Кондратьева Ю.С.,Зологина В.С., Торбик Д.В. Эффективность комбинированного лечения папилломавирусной инфекции Урология. 2015;2:39-42.
- Прилепская В.Н., Новикова Е.П. Возможности раннего лечения и профилактики папил-ломавирусной инфекции. Гинекология. 2013;15(1):94-7.
- Ambuhl L.M., Baandrup U., Dybkaer K., et al. Human papillomavirus infection as a possible cause of spontaneous abortion and spontaneous preterm delivery. Infect. Dis. Obstet. Gynecol. 2016;2016:3086036.
- Bassal R., Guilburd Y., Shapira H., et al. The clinical significance of HPV type in women with recurrent cytological atypia. Isr. Med. Assoc. J. 2018;20(3):172-75.
- Bosch F.X., Broker T.R., Forman D., et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31(7):H1-H31.
- Cheng J.X., Yao L.L., Xiang H., et al. Cervical cytology ASCUS patients with HPV detection and clinical value. Clin.Exp. Obstet. Gynecol. 2016;43(4):592-96.
- Cho G., Min K.J., Hong H.R., et al. High-risk human papillomavirus infection is associated with premature rupture of membranes. BMC Pregnancy Childbirth. 2013;13:173.
- Damin D.C., Ziegelmann P.K., Damin A.P. Human papillomavirus infection and colorectal cancer risk: a meta-analysis. Colorectal. Dis. 2013;15:e420-8.
- Denny L.A., Franceschi S., de Sanjose S., et al. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine. 2012;30(5):168-74.
- Depuydt C.E., Verstraete L., Berth M., et al. Human papillomavirus positivity in women undergoing intrauterine insemination has a negative effect on pregnancy rates. Gynecol. Obstet. Invest. 2016;81:41-6.
- Einstein M.H., Schiller J.T., Viscidi R.P, et al. Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect. Dis. 2009;9:347-56.
- Larasati L., Afiyanti Y., Rahmah H., Milanti A. Women's knowledge, beliefs, and behaviors toward the prevention of human papillomavirus transmission. Enferm. Clin. 2018;28(1): 191-94.
- Lasek W., Janyst M., Wolny R., et al. Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes. Acta Pharm. 2015;65(2):171-80.
- Majewska A, Lasek W, Janyst M, Miynarczyk G.) In vitro infibition of HHV-1 replication by inosine pranobex and interferon-a. Acta Pol. Pharm. 2016;73(3):637-44.
- Majewska A,. Lasek W., Przybylski M., et al. Interferon-a and inosine pranobex-mediated inhibition of reploication of human RNA viruses in vitro. Med. Dosw. Mikrobiol. 2016; 68(1):64-71.
- Manawapat-Klopfer A., Wang L., Haedicke-Jarboui J., et al. HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections. Am. J. Cancer Res. 2018; 8(4):715-22.
- Petrova M., Jelev D., Ivanova A., Krastev Z. Isoprinosine affects serum cytokine levels in healthy adults. J. Interferon Cytokine Res. 2010;30(4):223-28.
- Rerucha C.M., Caro R.J., Wheeler V.L. Cervical Cancer Screening. Am. Fam. Physician. 2018;97(7):441-48.
- Schmidt D. The new S3 guideline «Prevention of cervical carcinoma»: What is important for pathology? Pathologe. 2018;39(3):269-79.
Supplementary files
